Stan Kaye - Profile
Professor Stan Kaye is currently Head of the Drug Development Unit at The Institute of Cancer Research. He is also the Head of the Section of Medicine with our partner hospital, The Royal Marsden NHS Foundation Trust.
Prof Kaye is head of the world’s largest Phase I Unit which is leading approximately 30 current new drug trials. Over 200 patients per year now enter Phase I trials in the Unit.
Professor Kaye joined the Institute of Cancer Research in September 2000 after 20 years in Glasgow, 15 of which were spent as Head of Medical Oncology at Glasgow University.
He qualified in medicine in 1972 in London, and completed training in medicine and oncology in London and Australia. His major specialities include drug development, drug resistance and ovarian cancer.
The author of more than 350 peer reviewed papers, he sits on the Editorial Board of 12 cancer journals, and has held various national and international responsibilities.
Professor Kaye came to the ICR because ‘it is one of the best places in the world to do clinical new drug development’. He says his field of cancer research is ‘rewarding and exciting’, but wishes he had more time to see the world. In the small amount of spare time he has, Professor Kaye enjoys walking and squash.
